Is Bliss GVS Pharma Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Bliss GVS Pharma Ltd (BLISSGVS.NS) is currently classified as DOUBTFUL as of December 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Bliss GVS Pharma Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bliss GVS Pharma Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Bliss GVS Pharma Ltd?

Muslim investors may consider investing in Bliss GVS Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Bliss GVS Pharma Ltd classified as DOUBTFUL?

Musaffa determines the Shariah status of Bliss GVS Pharma Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Bliss GVS Pharma Ltd updated?

The Shariah compliance status of Bliss GVS Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Bliss GVS Pharma Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Bliss GVS Pharma Ltd?

You can check the latest Shariah compliance status of Bliss GVS Pharma Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BLISSGVS.NS Shariah Compliance

Screening Methodology: AAOIFI

DOUBTFUL

Last Updated: December 25, 2025

Report Source: 2026 2nd Quarter Report

Bliss GVS Pharma Ltd. Stock Analysis BLISSGVS.NS

India Health Care Small Cap Report: Q2, 2026

Bliss GVS Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations. The Company’s product categories include pharma products, other healthcare products, and therapeutic index. Its pharma products include pharma products include capsules, creams, gels, ointments, dry powder for injection, effervescent tablets, eye/ear drops, nasal solution, lotions, lozenges, oral solids, and others. The Company’s other healthcare products include balm, nasal inhaler, solution, soap, roll on, shampoo, powder, spray, and petroleum jelly. Its brands include ANOMEX, ANOMEX DS, CONLAX 5/10, G - ALFENAC 100, GACET 80/125/170/250/500/1G, GMETH - 50/100, GSUNATE - 50/100/200, GVCAM - 7.5/15, GV-SOFT 1/2/3/4 G, LOFNAC - 12.5/25/50/100, MEFINOL, MELANEZ, MENINA - 25/100, TYRIDOL, VIGOTAMIN, COMIT 50, BG - CLIND, VAGID CL, ECOZOLE, GVGYL 500, GYNANFORT, GVGYL N, KLOVINAL, LONART, LONART FORTE, LONART Dispersible, FINMOL, GACET-500, NOVOGLIP-5, GVZOLE, and DOXYCYCLINE.

Key Statistics of Bliss GVS Pharma Ltd (BLISSGVS.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹272.90₹287.50

Today's Open

₹287.20

Volume

3.06M

P/E Ratio (TTM)

36.25

52 Week Range

₹114.60₹293.00

Market Cap

29.03B

Avg. Volume

1.75M

Dividend Yield

0.18%

Financial Metrics & Statements of Bliss GVS Pharma Ltd (BLISSGVS.NS)

FAQ's for Bliss GVS Pharma Ltd (BLISSGVS.NS)

According to Musaffa’s Shariah screening methodology, Bliss GVS Pharma Ltd (BLISSGVS.NS) is currently classified as DOUBTFUL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.